Loading...
XSTO
ACOU
Market cap4mUSD
May 07, Last price  
3.21SEK
1D
-8.29%
1Q
-62.24%
IPO
-84.57%
Name

Acousort AB

Chart & Performance

D1W1MN
XSTO:ACOU chart
No data to show
P/E
—
P/S
10.10
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.78%
Rev. gr., 5y
20.61%
Revenues
5m
-55.10%
832,5471,947,1171,575,3492,722,0002,482,0001,074,0001,856,0004,928,0003,007,0004,963,00010,551,0004,737,000
Net income
-15m
L-11.77%
-62,720108,009-278,849-830,000-6,072,000-8,960,000-9,683,000-8,220,000-12,381,000-13,211,000-17,089,000-15,078,000
CFO
-19m
L-40.41%
-3,012,000-8,597,000-757,000-214,000-8,525,000-7,397,000-9,843,000-7,035,000-10,918,0003,965,000-31,559,000-18,807,000

Profile

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.
URL
https://acousort.com/
IPO date
Jan 09, 2017
Employees
13
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,737
-55.10%
10,551
112.59%
4,963
65.05%
Cost of revenue
(34)
2,162
8,564
Unusual Expense (Income)
NOPBT
4,771
8,389
(3,601)
NOPBT Margin
100.72%
79.51%
Operating Taxes
(569)
Tax Rate
NOPAT
4,771
8,389
(3,032)
Net income
(15,078)
-11.77%
(17,089)
29.35%
(13,211)
6.70%
Dividends
Dividend yield
Proceeds from repurchase of equity
(157)
22,079
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
1,046
Net debt
(3,568)
(24,010)
(33,974)
Cash flow
Cash from operating activities
(18,807)
(31,559)
3,965
CAPEX
(1,028)
(213)
(1,011)
Cash from investing activities
(1,016)
(1,155)
(1,011)
Cash from financing activities
(157)
22,079
FCF
4,377
8,839
(2,523)
Balance
Cash
3,568
23,986
33,974
Long term investments
24
Excess cash
3,331
23,482
33,726
Stockholders' equity
(90,609)
(75,143)
(59,979)
Invested Capital
99,072
99,278
80,051
ROIC
4.81%
9.36%
ROCE
56.37%
34.76%
EV
Common stock shares outstanding
15,059
13,294
13,259
Price
Market cap
EV
EBITDA
5,004
9,172
(2,680)
EV/EBITDA
Interest
15
Interest/NOPBT